Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifevantage (LFVN) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Lifevantage (LFVN) over the last 14 years, with Q4 2025 value amounting to $164000.0.

  • Lifevantage's Gains from Investment Securities fell 8173.72% to $164000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $4.9 million, marking a year-over-year increase of 17220.36%. This contributed to the annual value of $2.7 million for FY2025, which is 11818.18% up from last year.
  • Latest data reveals that Lifevantage reported Gains from Investment Securities of $164000.0 as of Q4 2025, which was down 8173.72% from $3.3 million recorded in Q3 2025.
  • In the past 5 years, Lifevantage's Gains from Investment Securities registered a high of $3.3 million during Q3 2025, and its lowest value of $19000.0 during Q4 2022.
  • For the 5-year period, Lifevantage's Gains from Investment Securities averaged around $401200.0, with its median value being $151500.0 (2021).
  • As far as peak fluctuations go, Lifevantage's Gains from Investment Securities plummeted by 9534.53% in 2021, and later surged by 102105.26% in 2023.
  • Over the past 5 years, Lifevantage's Gains from Investment Securities (Quarter) stood at $31000.0 in 2021, then plummeted by 38.71% to $19000.0 in 2022, then skyrocketed by 1021.05% to $213000.0 in 2023, then soared by 321.6% to $898000.0 in 2024, then tumbled by 81.74% to $164000.0 in 2025.
  • Its last three reported values are $164000.0 in Q4 2025, $3.3 million for Q3 2025, and $648000.0 during Q2 2025.